Table S4 from TTK Inhibitors as a Targeted Therapy for CTNNB1 (β-catenin) Mutant Cancers

Authors :: Joost C.M. Uitdehaag
Rogier C. Buijsman
Jos de Man
Martine B.W. Prinsen
Marion A.A. Libouban
Jeroen A.D.M. de Roos
Guido J.R. Zaman
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Gene Set Analysis of NTRC 0066-0 response

Full Text Access

Tools